logo

For the Inventor, By the Inventor

Salt Lake City, UT, United States of America

Steven G Kultgen

This inventor holds 9 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Tolero Pharmaceuticals, Inc., Pharmacopeia Drug Discovery, Inc., Msd Oss B.v.. Active years: 2005-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven G Kultgen. Retrieved from https://idiyas.com/inventor/steven-g-kultgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 55.6

 

Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Dayton, NJ (US) (2005 - 2011)
  • Salt Lake City, UT (US) (2012 - 2020)

Company Filing History:

goldMedal3 out of 21 
 
Tolero Pharmaceuticals, Inc.
 patents
silverMedal2 out of 52 
 
Pharmacopeia Drug Discovery, Inc.
 patents
bronzeMedal1 out of 17 
 
Msd Oss B.v.
 patents
4. 1 out of 101 
 
N.v. Organon
 patents
5. 1 out of 1 
 
Pharmacopeia Drug Disclovery, Inc.
 patent
6. 1 out of 11 
 
Sumitomo Dainippon Pharma Oncology, Inc.
 patents

Years Active: 2005-2020

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 10875864 - Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors (2020-12-29),
2. 10392392 - Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors (2019-08-27),
3. 10047093 - Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors (2018-08-14),
4. 9416132 - Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors (2016-08-16),
5. 8211927 - 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators (2012-07-03),
6. 7960365 - Compounds with medicinal effects due to interaction with the glucocorticoid receptor (2011-06-14),
7. 7084154 - 2-(aminomethyl) arylamide analgesics (2006-08-01),
8. 7037916 - Pyrimidine derivatives as IL-8 receptor antagonists (2006-05-02),
9. 6900213 - Bisaryl derivatives having FSH modulatory activity (2005-05-31),

Title: The Innovative Journey of Steven G Kultgen

Introduction: Steven G Kultgen is a renowned inventor based in Salt Lake City, UT (US) known for his groundbreaking contributions to various industries.

Latest Patents: Steven G Kultgen holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: With a career spanning over two decades, Steven G Kultgen has worked with leading companies to develop cutting-edge solutions that have revolutionized the market.

Collaborations: Throughout his career, Steven G Kultgen has collaborated with top researchers, engineers, and designers to bring his ideas to life, resulting in successful products that have made a significant impact.

Conclusion: Steven G Kultgen's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…